Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidiasis
- First Posted Date
- 2011-12-22
- Last Posted Date
- 2013-04-04
- Lead Sponsor
- MethylGene Inc.
- Target Recruit Count
- 220
- Registration Number
- NCT01497223
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Women's Health Care Research Corp., San Diego, California, United States
🇺🇸Altus Research, Lake Worth, Florida, United States
News
No news found